Global Canine Vaccine Market Growth 2026-2032
The global Canine Vaccine market size is predicted to grow from US$ 1795 million in 2025 to US$ 2699 million in 2032; it is expected to grow at a CAGR of 6.1% from 2026 to 2032.
Canine vaccines can be divided into two categories: core vaccines and non-core vaccines. The so-called core vaccines are vaccines that are necessary for serious diseases with high infectiousness and high mortality rates, including rabies virus, distemper virus, canine adenovirus and canine parvovirus. Non-core vaccines can be evaluated based on the dog's living environment and physical condition to determine whether to vaccinate, including canine parainfluenza virus, leptospirosis, etc.
United States market for Canine Vaccine is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
China market for Canine Vaccine is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Europe market for Canine Vaccine is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Global key Canine Vaccine players cover Zoetis, Merck Animal Health, Pfizer, Boehringer Ingelheim, Virbac, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2025.
LP Information, Inc. (LPI) ' newest research report, the ?Canine Vaccine Industry Forecast? looks at past sales and reviews total world Canine Vaccine sales in 2025, providing a comprehensive analysis by region and market sector of projected Canine Vaccine sales for 2026 through 2032. With Canine Vaccine sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Canine Vaccine industry.
This Insight Report provides a comprehensive analysis of the global Canine Vaccine landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Canine Vaccine portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms? unique position in an accelerating global Canine Vaccine market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Canine Vaccine and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Canine Vaccine.
This report presents a comprehensive overview, market shares, and growth opportunities of Canine Vaccine market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
What is the 10-year outlook for the global Canine Vaccine market?
What factors are driving Canine Vaccine market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Canine Vaccine market opportunities vary by end market size?
How does Canine Vaccine break out by Type, by Application?
Canine vaccines can be divided into two categories: core vaccines and non-core vaccines. The so-called core vaccines are vaccines that are necessary for serious diseases with high infectiousness and high mortality rates, including rabies virus, distemper virus, canine adenovirus and canine parvovirus. Non-core vaccines can be evaluated based on the dog's living environment and physical condition to determine whether to vaccinate, including canine parainfluenza virus, leptospirosis, etc.
United States market for Canine Vaccine is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
China market for Canine Vaccine is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Europe market for Canine Vaccine is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Global key Canine Vaccine players cover Zoetis, Merck Animal Health, Pfizer, Boehringer Ingelheim, Virbac, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2025.
LP Information, Inc. (LPI) ' newest research report, the ?Canine Vaccine Industry Forecast? looks at past sales and reviews total world Canine Vaccine sales in 2025, providing a comprehensive analysis by region and market sector of projected Canine Vaccine sales for 2026 through 2032. With Canine Vaccine sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Canine Vaccine industry.
This Insight Report provides a comprehensive analysis of the global Canine Vaccine landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Canine Vaccine portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms? unique position in an accelerating global Canine Vaccine market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Canine Vaccine and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Canine Vaccine.
This report presents a comprehensive overview, market shares, and growth opportunities of Canine Vaccine market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
- Core Vaccines
- Non-Core Vaccines
- Puppies
- Adult Dogs
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Zoetis
- Merck Animal Health
- Pfizer
- Boehringer Ingelheim
- Virbac
- Durvet
- Elanco
- RuiPu Bio-Technology
- CAHIC
- Wuhan Keqian Biology
- Jilin Five-Star Animal Health
- NeoTech
- JINHE
- SINOVAC
- Biogenesis Bago
What is the 10-year outlook for the global Canine Vaccine market?
What factors are driving Canine Vaccine market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Canine Vaccine market opportunities vary by end market size?
How does Canine Vaccine break out by Type, by Application?
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Canine Vaccine Annual Sales 2021-2032
2.1.2 World Current & Future Analysis for Canine Vaccine by Geographic Region, 2021, 2025 & 2032
2.1.3 World Current & Future Analysis for Canine Vaccine by Country/Region, 2021, 2025 & 2032
2.2 Canine Vaccine Segment by Type
2.2.1 Core Vaccines
2.2.2 Non-Core Vaccines
2.2.3 Canine Vaccine Sales by Type
2.2.3.1 Global Canine Vaccine Sales Market Share by Type (2021-2026)
2.2.3.2 Global Canine Vaccine Revenue and Market Share by Type (2021-2026)
2.2.3.3 Global Canine Vaccine Sale Price by Type (2021-2026)
2.3 Canine Vaccine Segment by Application
2.3.1 Puppies
2.3.2 Adult Dogs
2.3.3 Canine Vaccine Sales by Application
2.3.3.1 Global Canine Vaccine Sale Market Share by Application (2021-2026)
2.3.3.2 Global Canine Vaccine Revenue and Market Share by Application (2021-2026)
2.3.3.3 Global Canine Vaccine Sale Price by Application (2021-2026)
3 GLOBAL BY COMPANY
3.1 Global Canine Vaccine Breakdown Data by Company
3.1.1 Global Canine Vaccine Annual Sales by Company (2021-2026)
3.1.2 Global Canine Vaccine Sales Market Share by Company (2021-2026)
3.2 Global Canine Vaccine Annual Revenue by Company (2021-2026)
3.2.1 Global Canine Vaccine Revenue by Company (2021-2026)
3.2.2 Global Canine Vaccine Revenue Market Share by Company (2021-2026)
3.3 Global Canine Vaccine Sale Price by Company
3.4 Key Manufacturers Canine Vaccine Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Canine Vaccine Product Location Distribution
3.4.2 Players Canine Vaccine Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR CANINE VACCINE BY GEOGRAPHIC REGION
4.1 World Historic Canine Vaccine Market Size by Geographic Region (2021-2026)
4.1.1 Global Canine Vaccine Annual Sales by Geographic Region (2021-2026)
4.1.2 Global Canine Vaccine Annual Revenue by Geographic Region (2021-2026)
4.2 World Historic Canine Vaccine Market Size by Country/Region (2021-2026)
4.2.1 Global Canine Vaccine Annual Sales by Country/Region (2021-2026)
4.2.2 Global Canine Vaccine Annual Revenue by Country/Region (2021-2026)
4.3 Americas Canine Vaccine Sales Growth
4.4 APAC Canine Vaccine Sales Growth
4.5 Europe Canine Vaccine Sales Growth
4.6 Middle East & Africa Canine Vaccine Sales Growth
5 AMERICAS
5.1 Americas Canine Vaccine Sales by Country
5.1.1 Americas Canine Vaccine Sales by Country (2021-2026)
5.1.2 Americas Canine Vaccine Revenue by Country (2021-2026)
5.2 Americas Canine Vaccine Sales by Type (2021-2026)
5.3 Americas Canine Vaccine Sales by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Canine Vaccine Sales by Region
6.1.1 APAC Canine Vaccine Sales by Region (2021-2026)
6.1.2 APAC Canine Vaccine Revenue by Region (2021-2026)
6.2 APAC Canine Vaccine Sales by Type (2021-2026)
6.3 APAC Canine Vaccine Sales by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Canine Vaccine by Country
7.1.1 Europe Canine Vaccine Sales by Country (2021-2026)
7.1.2 Europe Canine Vaccine Revenue by Country (2021-2026)
7.2 Europe Canine Vaccine Sales by Type (2021-2026)
7.3 Europe Canine Vaccine Sales by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Canine Vaccine by Country
8.1.1 Middle East & Africa Canine Vaccine Sales by Country (2021-2026)
8.1.2 Middle East & Africa Canine Vaccine Revenue by Country (2021-2026)
8.2 Middle East & Africa Canine Vaccine Sales by Type (2021-2026)
8.3 Middle East & Africa Canine Vaccine Sales by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Canine Vaccine
10.3 Manufacturing Process Analysis of Canine Vaccine
10.4 Industry Chain Structure of Canine Vaccine
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Canine Vaccine Distributors
11.3 Canine Vaccine Customer
12 WORLD FORECAST REVIEW FOR CANINE VACCINE BY GEOGRAPHIC REGION
12.1 Global Canine Vaccine Market Size Forecast by Region
12.1.1 Global Canine Vaccine Forecast by Region (2027-2032)
12.1.2 Global Canine Vaccine Annual Revenue Forecast by Region (2027-2032)
12.2 Americas Forecast by Country (2027-2032)
12.3 APAC Forecast by Region (2027-2032)
12.4 Europe Forecast by Country (2027-2032)
12.5 Middle East & Africa Forecast by Country (2027-2032)
12.6 Global Canine Vaccine Forecast by Type (2027-2032)
12.7 Global Canine Vaccine Forecast by Application (2027-2032)
13 KEY PLAYERS ANALYSIS
13.1 Zoetis
13.1.1 Zoetis Company Information
13.1.2 Zoetis Canine Vaccine Product Portfolios and Specifications
13.1.3 Zoetis Canine Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
13.1.4 Zoetis Main Business Overview
13.1.5 Zoetis Latest Developments
13.2 Merck Animal Health
13.2.1 Merck Animal Health Company Information
13.2.2 Merck Animal Health Canine Vaccine Product Portfolios and Specifications
13.2.3 Merck Animal Health Canine Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
13.2.4 Merck Animal Health Main Business Overview
13.2.5 Merck Animal Health Latest Developments
13.3 Pfizer
13.3.1 Pfizer Company Information
13.3.2 Pfizer Canine Vaccine Product Portfolios and Specifications
13.3.3 Pfizer Canine Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
13.3.4 Pfizer Main Business Overview
13.3.5 Pfizer Latest Developments
13.4 Boehringer Ingelheim
13.4.1 Boehringer Ingelheim Company Information
13.4.2 Boehringer Ingelheim Canine Vaccine Product Portfolios and Specifications
13.4.3 Boehringer Ingelheim Canine Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
13.4.4 Boehringer Ingelheim Main Business Overview
13.4.5 Boehringer Ingelheim Latest Developments
13.5 Virbac
13.5.1 Virbac Company Information
13.5.2 Virbac Canine Vaccine Product Portfolios and Specifications
13.5.3 Virbac Canine Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
13.5.4 Virbac Main Business Overview
13.5.5 Virbac Latest Developments
13.6 Durvet
13.6.1 Durvet Company Information
13.6.2 Durvet Canine Vaccine Product Portfolios and Specifications
13.6.3 Durvet Canine Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
13.6.4 Durvet Main Business Overview
13.6.5 Durvet Latest Developments
13.7 Elanco
13.7.1 Elanco Company Information
13.7.2 Elanco Canine Vaccine Product Portfolios and Specifications
13.7.3 Elanco Canine Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
13.7.4 Elanco Main Business Overview
13.7.5 Elanco Latest Developments
13.8 RuiPu Bio-Technology
13.8.1 RuiPu Bio-Technology Company Information
13.8.2 RuiPu Bio-Technology Canine Vaccine Product Portfolios and Specifications
13.8.3 RuiPu Bio-Technology Canine Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
13.8.4 RuiPu Bio-Technology Main Business Overview
13.8.5 RuiPu Bio-Technology Latest Developments
13.9 CAHIC
13.9.1 CAHIC Company Information
13.9.2 CAHIC Canine Vaccine Product Portfolios and Specifications
13.9.3 CAHIC Canine Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
13.9.4 CAHIC Main Business Overview
13.9.5 CAHIC Latest Developments
13.10 Wuhan Keqian Biology
13.10.1 Wuhan Keqian Biology Company Information
13.10.2 Wuhan Keqian Biology Canine Vaccine Product Portfolios and Specifications
13.10.3 Wuhan Keqian Biology Canine Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
13.10.4 Wuhan Keqian Biology Main Business Overview
13.10.5 Wuhan Keqian Biology Latest Developments
13.11 Jilin Five-Star Animal Health
13.11.1 Jilin Five-Star Animal Health Company Information
13.11.2 Jilin Five-Star Animal Health Canine Vaccine Product Portfolios and Specifications
13.11.3 Jilin Five-Star Animal Health Canine Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
13.11.4 Jilin Five-Star Animal Health Main Business Overview
13.11.5 Jilin Five-Star Animal Health Latest Developments
13.12 NeoTech
13.12.1 NeoTech Company Information
13.12.2 NeoTech Canine Vaccine Product Portfolios and Specifications
13.12.3 NeoTech Canine Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
13.12.4 NeoTech Main Business Overview
13.12.5 NeoTech Latest Developments
13.13 JINHE
13.13.1 JINHE Company Information
13.13.2 JINHE Canine Vaccine Product Portfolios and Specifications
13.13.3 JINHE Canine Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
13.13.4 JINHE Main Business Overview
13.13.5 JINHE Latest Developments
13.14 SINOVAC
13.14.1 SINOVAC Company Information
13.14.2 SINOVAC Canine Vaccine Product Portfolios and Specifications
13.14.3 SINOVAC Canine Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
13.14.4 SINOVAC Main Business Overview
13.14.5 SINOVAC Latest Developments
13.15 Biogenesis Bago
13.15.1 Biogenesis Bago Company Information
13.15.2 Biogenesis Bago Canine Vaccine Product Portfolios and Specifications
13.15.3 Biogenesis Bago Canine Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
13.15.4 Biogenesis Bago Main Business Overview
13.15.5 Biogenesis Bago Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Canine Vaccine Annual Sales 2021-2032
2.1.2 World Current & Future Analysis for Canine Vaccine by Geographic Region, 2021, 2025 & 2032
2.1.3 World Current & Future Analysis for Canine Vaccine by Country/Region, 2021, 2025 & 2032
2.2 Canine Vaccine Segment by Type
2.2.1 Core Vaccines
2.2.2 Non-Core Vaccines
2.2.3 Canine Vaccine Sales by Type
2.2.3.1 Global Canine Vaccine Sales Market Share by Type (2021-2026)
2.2.3.2 Global Canine Vaccine Revenue and Market Share by Type (2021-2026)
2.2.3.3 Global Canine Vaccine Sale Price by Type (2021-2026)
2.3 Canine Vaccine Segment by Application
2.3.1 Puppies
2.3.2 Adult Dogs
2.3.3 Canine Vaccine Sales by Application
2.3.3.1 Global Canine Vaccine Sale Market Share by Application (2021-2026)
2.3.3.2 Global Canine Vaccine Revenue and Market Share by Application (2021-2026)
2.3.3.3 Global Canine Vaccine Sale Price by Application (2021-2026)
3 GLOBAL BY COMPANY
3.1 Global Canine Vaccine Breakdown Data by Company
3.1.1 Global Canine Vaccine Annual Sales by Company (2021-2026)
3.1.2 Global Canine Vaccine Sales Market Share by Company (2021-2026)
3.2 Global Canine Vaccine Annual Revenue by Company (2021-2026)
3.2.1 Global Canine Vaccine Revenue by Company (2021-2026)
3.2.2 Global Canine Vaccine Revenue Market Share by Company (2021-2026)
3.3 Global Canine Vaccine Sale Price by Company
3.4 Key Manufacturers Canine Vaccine Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Canine Vaccine Product Location Distribution
3.4.2 Players Canine Vaccine Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR CANINE VACCINE BY GEOGRAPHIC REGION
4.1 World Historic Canine Vaccine Market Size by Geographic Region (2021-2026)
4.1.1 Global Canine Vaccine Annual Sales by Geographic Region (2021-2026)
4.1.2 Global Canine Vaccine Annual Revenue by Geographic Region (2021-2026)
4.2 World Historic Canine Vaccine Market Size by Country/Region (2021-2026)
4.2.1 Global Canine Vaccine Annual Sales by Country/Region (2021-2026)
4.2.2 Global Canine Vaccine Annual Revenue by Country/Region (2021-2026)
4.3 Americas Canine Vaccine Sales Growth
4.4 APAC Canine Vaccine Sales Growth
4.5 Europe Canine Vaccine Sales Growth
4.6 Middle East & Africa Canine Vaccine Sales Growth
5 AMERICAS
5.1 Americas Canine Vaccine Sales by Country
5.1.1 Americas Canine Vaccine Sales by Country (2021-2026)
5.1.2 Americas Canine Vaccine Revenue by Country (2021-2026)
5.2 Americas Canine Vaccine Sales by Type (2021-2026)
5.3 Americas Canine Vaccine Sales by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Canine Vaccine Sales by Region
6.1.1 APAC Canine Vaccine Sales by Region (2021-2026)
6.1.2 APAC Canine Vaccine Revenue by Region (2021-2026)
6.2 APAC Canine Vaccine Sales by Type (2021-2026)
6.3 APAC Canine Vaccine Sales by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Canine Vaccine by Country
7.1.1 Europe Canine Vaccine Sales by Country (2021-2026)
7.1.2 Europe Canine Vaccine Revenue by Country (2021-2026)
7.2 Europe Canine Vaccine Sales by Type (2021-2026)
7.3 Europe Canine Vaccine Sales by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Canine Vaccine by Country
8.1.1 Middle East & Africa Canine Vaccine Sales by Country (2021-2026)
8.1.2 Middle East & Africa Canine Vaccine Revenue by Country (2021-2026)
8.2 Middle East & Africa Canine Vaccine Sales by Type (2021-2026)
8.3 Middle East & Africa Canine Vaccine Sales by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Canine Vaccine
10.3 Manufacturing Process Analysis of Canine Vaccine
10.4 Industry Chain Structure of Canine Vaccine
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Canine Vaccine Distributors
11.3 Canine Vaccine Customer
12 WORLD FORECAST REVIEW FOR CANINE VACCINE BY GEOGRAPHIC REGION
12.1 Global Canine Vaccine Market Size Forecast by Region
12.1.1 Global Canine Vaccine Forecast by Region (2027-2032)
12.1.2 Global Canine Vaccine Annual Revenue Forecast by Region (2027-2032)
12.2 Americas Forecast by Country (2027-2032)
12.3 APAC Forecast by Region (2027-2032)
12.4 Europe Forecast by Country (2027-2032)
12.5 Middle East & Africa Forecast by Country (2027-2032)
12.6 Global Canine Vaccine Forecast by Type (2027-2032)
12.7 Global Canine Vaccine Forecast by Application (2027-2032)
13 KEY PLAYERS ANALYSIS
13.1 Zoetis
13.1.1 Zoetis Company Information
13.1.2 Zoetis Canine Vaccine Product Portfolios and Specifications
13.1.3 Zoetis Canine Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
13.1.4 Zoetis Main Business Overview
13.1.5 Zoetis Latest Developments
13.2 Merck Animal Health
13.2.1 Merck Animal Health Company Information
13.2.2 Merck Animal Health Canine Vaccine Product Portfolios and Specifications
13.2.3 Merck Animal Health Canine Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
13.2.4 Merck Animal Health Main Business Overview
13.2.5 Merck Animal Health Latest Developments
13.3 Pfizer
13.3.1 Pfizer Company Information
13.3.2 Pfizer Canine Vaccine Product Portfolios and Specifications
13.3.3 Pfizer Canine Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
13.3.4 Pfizer Main Business Overview
13.3.5 Pfizer Latest Developments
13.4 Boehringer Ingelheim
13.4.1 Boehringer Ingelheim Company Information
13.4.2 Boehringer Ingelheim Canine Vaccine Product Portfolios and Specifications
13.4.3 Boehringer Ingelheim Canine Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
13.4.4 Boehringer Ingelheim Main Business Overview
13.4.5 Boehringer Ingelheim Latest Developments
13.5 Virbac
13.5.1 Virbac Company Information
13.5.2 Virbac Canine Vaccine Product Portfolios and Specifications
13.5.3 Virbac Canine Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
13.5.4 Virbac Main Business Overview
13.5.5 Virbac Latest Developments
13.6 Durvet
13.6.1 Durvet Company Information
13.6.2 Durvet Canine Vaccine Product Portfolios and Specifications
13.6.3 Durvet Canine Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
13.6.4 Durvet Main Business Overview
13.6.5 Durvet Latest Developments
13.7 Elanco
13.7.1 Elanco Company Information
13.7.2 Elanco Canine Vaccine Product Portfolios and Specifications
13.7.3 Elanco Canine Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
13.7.4 Elanco Main Business Overview
13.7.5 Elanco Latest Developments
13.8 RuiPu Bio-Technology
13.8.1 RuiPu Bio-Technology Company Information
13.8.2 RuiPu Bio-Technology Canine Vaccine Product Portfolios and Specifications
13.8.3 RuiPu Bio-Technology Canine Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
13.8.4 RuiPu Bio-Technology Main Business Overview
13.8.5 RuiPu Bio-Technology Latest Developments
13.9 CAHIC
13.9.1 CAHIC Company Information
13.9.2 CAHIC Canine Vaccine Product Portfolios and Specifications
13.9.3 CAHIC Canine Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
13.9.4 CAHIC Main Business Overview
13.9.5 CAHIC Latest Developments
13.10 Wuhan Keqian Biology
13.10.1 Wuhan Keqian Biology Company Information
13.10.2 Wuhan Keqian Biology Canine Vaccine Product Portfolios and Specifications
13.10.3 Wuhan Keqian Biology Canine Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
13.10.4 Wuhan Keqian Biology Main Business Overview
13.10.5 Wuhan Keqian Biology Latest Developments
13.11 Jilin Five-Star Animal Health
13.11.1 Jilin Five-Star Animal Health Company Information
13.11.2 Jilin Five-Star Animal Health Canine Vaccine Product Portfolios and Specifications
13.11.3 Jilin Five-Star Animal Health Canine Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
13.11.4 Jilin Five-Star Animal Health Main Business Overview
13.11.5 Jilin Five-Star Animal Health Latest Developments
13.12 NeoTech
13.12.1 NeoTech Company Information
13.12.2 NeoTech Canine Vaccine Product Portfolios and Specifications
13.12.3 NeoTech Canine Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
13.12.4 NeoTech Main Business Overview
13.12.5 NeoTech Latest Developments
13.13 JINHE
13.13.1 JINHE Company Information
13.13.2 JINHE Canine Vaccine Product Portfolios and Specifications
13.13.3 JINHE Canine Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
13.13.4 JINHE Main Business Overview
13.13.5 JINHE Latest Developments
13.14 SINOVAC
13.14.1 SINOVAC Company Information
13.14.2 SINOVAC Canine Vaccine Product Portfolios and Specifications
13.14.3 SINOVAC Canine Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
13.14.4 SINOVAC Main Business Overview
13.14.5 SINOVAC Latest Developments
13.15 Biogenesis Bago
13.15.1 Biogenesis Bago Company Information
13.15.2 Biogenesis Bago Canine Vaccine Product Portfolios and Specifications
13.15.3 Biogenesis Bago Canine Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
13.15.4 Biogenesis Bago Main Business Overview
13.15.5 Biogenesis Bago Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Canine Vaccine Annual Sales CAGR by Geographic Region (2021, 2025 & 2032) & ($ millions)
Table 2. Canine Vaccine Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of Core Vaccines
Table 4. Major Players of Non-Core Vaccines
Table 5. Global Canine Vaccine Sales by Type (2021-2026) & (K Units)
Table 6. Global Canine Vaccine Sales Market Share by Type (2021-2026)
Table 7. Global Canine Vaccine Revenue by Type (2021-2026) & ($ million)
Table 8. Global Canine Vaccine Revenue Market Share by Type (2021-2026)
Table 9. Global Canine Vaccine Sale Price by Type (2021-2026) & (US$/Unit)
Table 10. Global Canine Vaccine Sale by Application (2021-2026) & (K Units)
Table 11. Global Canine Vaccine Sale Market Share by Application (2021-2026)
Table 12. Global Canine Vaccine Revenue by Application (2021-2026) & ($ million)
Table 13. Global Canine Vaccine Revenue Market Share by Application (2021-2026)
Table 14. Global Canine Vaccine Sale Price by Application (2021-2026) & (US$/Unit)
Table 15. Global Canine Vaccine Sales by Company (2021-2026) & (K Units)
Table 16. Global Canine Vaccine Sales Market Share by Company (2021-2026)
Table 17. Global Canine Vaccine Revenue by Company (2021-2026) & ($ millions)
Table 18. Global Canine Vaccine Revenue Market Share by Company (2021-2026)
Table 19. Global Canine Vaccine Sale Price by Company (2021-2026) & (US$/Unit)
Table 20. Key Manufacturers Canine Vaccine Producing Area Distribution and Sales Area
Table 21. Players Canine Vaccine Products Offered
Table 22. Canine Vaccine Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 23. New Products and Potential Entrants
Table 24. Market M&A Activity & Strategy
Table 25. Global Canine Vaccine Sales by Geographic Region (2021-2026) & (K Units)
Table 26. Global Canine Vaccine Sales Market Share Geographic Region (2021-2026)
Table 27. Global Canine Vaccine Revenue by Geographic Region (2021-2026) & ($ millions)
Table 28. Global Canine Vaccine Revenue Market Share by Geographic Region (2021-2026)
Table 29. Global Canine Vaccine Sales by Country/Region (2021-2026) & (K Units)
Table 30. Global Canine Vaccine Sales Market Share by Country/Region (2021-2026)
Table 31. Global Canine Vaccine Revenue by Country/Region (2021-2026) & ($ millions)
Table 32. Global Canine Vaccine Revenue Market Share by Country/Region (2021-2026)
Table 33. Americas Canine Vaccine Sales by Country (2021-2026) & (K Units)
Table 34. Americas Canine Vaccine Sales Market Share by Country (2021-2026)
Table 35. Americas Canine Vaccine Revenue by Country (2021-2026) & ($ millions)
Table 36. Americas Canine Vaccine Sales by Type (2021-2026) & (K Units)
Table 37. Americas Canine Vaccine Sales by Application (2021-2026) & (K Units)
Table 38. APAC Canine Vaccine Sales by Region (2021-2026) & (K Units)
Table 39. APAC Canine Vaccine Sales Market Share by Region (2021-2026)
Table 40. APAC Canine Vaccine Revenue by Region (2021-2026) & ($ millions)
Table 41. APAC Canine Vaccine Sales by Type (2021-2026) & (K Units)
Table 42. APAC Canine Vaccine Sales by Application (2021-2026) & (K Units)
Table 43. Europe Canine Vaccine Sales by Country (2021-2026) & (K Units)
Table 44. Europe Canine Vaccine Revenue by Country (2021-2026) & ($ millions)
Table 45. Europe Canine Vaccine Sales by Type (2021-2026) & (K Units)
Table 46. Europe Canine Vaccine Sales by Application (2021-2026) & (K Units)
Table 47. Middle East & Africa Canine Vaccine Sales by Country (2021-2026) & (K Units)
Table 48. Middle East & Africa Canine Vaccine Revenue Market Share by Country (2021-2026)
Table 49. Middle East & Africa Canine Vaccine Sales by Type (2021-2026) & (K Units)
Table 50. Middle East & Africa Canine Vaccine Sales by Application (2021-2026) & (K Units)
Table 51. Key Market Drivers & Growth Opportunities of Canine Vaccine
Table 52. Key Market Challenges & Risks of Canine Vaccine
Table 53. Key Industry Trends of Canine Vaccine
Table 54. Canine Vaccine Raw Material
Table 55. Key Suppliers of Raw Materials
Table 56. Canine Vaccine Distributors List
Table 57. Canine Vaccine Customer List
Table 58. Global Canine Vaccine Sales Forecast by Region (2027-2032) & (K Units)
Table 59. Global Canine Vaccine Revenue Forecast by Region (2027-2032) & ($ millions)
Table 60. Americas Canine Vaccine Sales Forecast by Country (2027-2032) & (K Units)
Table 61. Americas Canine Vaccine Annual Revenue Forecast by Country (2027-2032) & ($ millions)
Table 62. APAC Canine Vaccine Sales Forecast by Region (2027-2032) & (K Units)
Table 63. APAC Canine Vaccine Annual Revenue Forecast by Region (2027-2032) & ($ millions)
Table 64. Europe Canine Vaccine Sales Forecast by Country (2027-2032) & (K Units)
Table 65. Europe Canine Vaccine Revenue Forecast by Country (2027-2032) & ($ millions)
Table 66. Middle East & Africa Canine Vaccine Sales Forecast by Country (2027-2032) & (K Units)
Table 67. Middle East & Africa Canine Vaccine Revenue Forecast by Country (2027-2032) & ($ millions)
Table 68. Global Canine Vaccine Sales Forecast by Type (2027-2032) & (K Units)
Table 69. Global Canine Vaccine Revenue Forecast by Type (2027-2032) & ($ millions)
Table 70. Global Canine Vaccine Sales Forecast by Application (2027-2032) & (K Units)
Table 71. Global Canine Vaccine Revenue Forecast by Application (2027-2032) & ($ millions)
Table 72. Zoetis Basic Information, Canine Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 73. Zoetis Canine Vaccine Product Portfolios and Specifications
Table 74. Zoetis Canine Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 75. Zoetis Main Business
Table 76. Zoetis Latest Developments
Table 77. Merck Animal Health Basic Information, Canine Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 78. Merck Animal Health Canine Vaccine Product Portfolios and Specifications
Table 79. Merck Animal Health Canine Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 80. Merck Animal Health Main Business
Table 81. Merck Animal Health Latest Developments
Table 82. Pfizer Basic Information, Canine Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 83. Pfizer Canine Vaccine Product Portfolios and Specifications
Table 84. Pfizer Canine Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 85. Pfizer Main Business
Table 86. Pfizer Latest Developments
Table 87. Boehringer Ingelheim Basic Information, Canine Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 88. Boehringer Ingelheim Canine Vaccine Product Portfolios and Specifications
Table 89. Boehringer Ingelheim Canine Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 90. Boehringer Ingelheim Main Business
Table 91. Boehringer Ingelheim Latest Developments
Table 92. Virbac Basic Information, Canine Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 93. Virbac Canine Vaccine Product Portfolios and Specifications
Table 94. Virbac Canine Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 95. Virbac Main Business
Table 96. Virbac Latest Developments
Table 97. Durvet Basic Information, Canine Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 98. Durvet Canine Vaccine Product Portfolios and Specifications
Table 99. Durvet Canine Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 100. Durvet Main Business
Table 101. Durvet Latest Developments
Table 102. Elanco Basic Information, Canine Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 103. Elanco Canine Vaccine Product Portfolios and Specifications
Table 104. Elanco Canine Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 105. Elanco Main Business
Table 106. Elanco Latest Developments
Table 107. RuiPu Bio-Technology Basic Information, Canine Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 108. RuiPu Bio-Technology Canine Vaccine Product Portfolios and Specifications
Table 109. RuiPu Bio-Technology Canine Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 110. RuiPu Bio-Technology Main Business
Table 111. RuiPu Bio-Technology Latest Developments
Table 112. CAHIC Basic Information, Canine Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 113. CAHIC Canine Vaccine Product Portfolios and Specifications
Table 114. CAHIC Canine Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 115. CAHIC Main Business
Table 116. CAHIC Latest Developments
Table 117. Wuhan Keqian Biology Basic Information, Canine Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 118. Wuhan Keqian Biology Canine Vaccine Product Portfolios and Specifications
Table 119. Wuhan Keqian Biology Canine Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 120. Wuhan Keqian Biology Main Business
Table 121. Wuhan Keqian Biology Latest Developments
Table 122. Jilin Five-Star Animal Health Basic Information, Canine Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 123. Jilin Five-Star Animal Health Canine Vaccine Product Portfolios and Specifications
Table 124. Jilin Five-Star Animal Health Canine Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 125. Jilin Five-Star Animal Health Main Business
Table 126. Jilin Five-Star Animal Health Latest Developments
Table 127. NeoTech Basic Information, Canine Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 128. NeoTech Canine Vaccine Product Portfolios and Specifications
Table 129. NeoTech Canine Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 130. NeoTech Main Business
Table 131. NeoTech Latest Developments
Table 132. JINHE Basic Information, Canine Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 133. JINHE Canine Vaccine Product Portfolios and Specifications
Table 134. JINHE Canine Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 135. JINHE Main Business
Table 136. JINHE Latest Developments
Table 137. SINOVAC Basic Information, Canine Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 138. SINOVAC Canine Vaccine Product Portfolios and Specifications
Table 139. SINOVAC Canine Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 140. SINOVAC Main Business
Table 141. SINOVAC Latest Developments
Table 142. Biogenesis Bago Basic Information, Canine Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 143. Biogenesis Bago Canine Vaccine Product Portfolios and Specifications
Table 144. Biogenesis Bago Canine Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 145. Biogenesis Bago Main Business
Table 146. Biogenesis Bago Latest Developments
Table 1. Canine Vaccine Annual Sales CAGR by Geographic Region (2021, 2025 & 2032) & ($ millions)
Table 2. Canine Vaccine Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of Core Vaccines
Table 4. Major Players of Non-Core Vaccines
Table 5. Global Canine Vaccine Sales by Type (2021-2026) & (K Units)
Table 6. Global Canine Vaccine Sales Market Share by Type (2021-2026)
Table 7. Global Canine Vaccine Revenue by Type (2021-2026) & ($ million)
Table 8. Global Canine Vaccine Revenue Market Share by Type (2021-2026)
Table 9. Global Canine Vaccine Sale Price by Type (2021-2026) & (US$/Unit)
Table 10. Global Canine Vaccine Sale by Application (2021-2026) & (K Units)
Table 11. Global Canine Vaccine Sale Market Share by Application (2021-2026)
Table 12. Global Canine Vaccine Revenue by Application (2021-2026) & ($ million)
Table 13. Global Canine Vaccine Revenue Market Share by Application (2021-2026)
Table 14. Global Canine Vaccine Sale Price by Application (2021-2026) & (US$/Unit)
Table 15. Global Canine Vaccine Sales by Company (2021-2026) & (K Units)
Table 16. Global Canine Vaccine Sales Market Share by Company (2021-2026)
Table 17. Global Canine Vaccine Revenue by Company (2021-2026) & ($ millions)
Table 18. Global Canine Vaccine Revenue Market Share by Company (2021-2026)
Table 19. Global Canine Vaccine Sale Price by Company (2021-2026) & (US$/Unit)
Table 20. Key Manufacturers Canine Vaccine Producing Area Distribution and Sales Area
Table 21. Players Canine Vaccine Products Offered
Table 22. Canine Vaccine Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 23. New Products and Potential Entrants
Table 24. Market M&A Activity & Strategy
Table 25. Global Canine Vaccine Sales by Geographic Region (2021-2026) & (K Units)
Table 26. Global Canine Vaccine Sales Market Share Geographic Region (2021-2026)
Table 27. Global Canine Vaccine Revenue by Geographic Region (2021-2026) & ($ millions)
Table 28. Global Canine Vaccine Revenue Market Share by Geographic Region (2021-2026)
Table 29. Global Canine Vaccine Sales by Country/Region (2021-2026) & (K Units)
Table 30. Global Canine Vaccine Sales Market Share by Country/Region (2021-2026)
Table 31. Global Canine Vaccine Revenue by Country/Region (2021-2026) & ($ millions)
Table 32. Global Canine Vaccine Revenue Market Share by Country/Region (2021-2026)
Table 33. Americas Canine Vaccine Sales by Country (2021-2026) & (K Units)
Table 34. Americas Canine Vaccine Sales Market Share by Country (2021-2026)
Table 35. Americas Canine Vaccine Revenue by Country (2021-2026) & ($ millions)
Table 36. Americas Canine Vaccine Sales by Type (2021-2026) & (K Units)
Table 37. Americas Canine Vaccine Sales by Application (2021-2026) & (K Units)
Table 38. APAC Canine Vaccine Sales by Region (2021-2026) & (K Units)
Table 39. APAC Canine Vaccine Sales Market Share by Region (2021-2026)
Table 40. APAC Canine Vaccine Revenue by Region (2021-2026) & ($ millions)
Table 41. APAC Canine Vaccine Sales by Type (2021-2026) & (K Units)
Table 42. APAC Canine Vaccine Sales by Application (2021-2026) & (K Units)
Table 43. Europe Canine Vaccine Sales by Country (2021-2026) & (K Units)
Table 44. Europe Canine Vaccine Revenue by Country (2021-2026) & ($ millions)
Table 45. Europe Canine Vaccine Sales by Type (2021-2026) & (K Units)
Table 46. Europe Canine Vaccine Sales by Application (2021-2026) & (K Units)
Table 47. Middle East & Africa Canine Vaccine Sales by Country (2021-2026) & (K Units)
Table 48. Middle East & Africa Canine Vaccine Revenue Market Share by Country (2021-2026)
Table 49. Middle East & Africa Canine Vaccine Sales by Type (2021-2026) & (K Units)
Table 50. Middle East & Africa Canine Vaccine Sales by Application (2021-2026) & (K Units)
Table 51. Key Market Drivers & Growth Opportunities of Canine Vaccine
Table 52. Key Market Challenges & Risks of Canine Vaccine
Table 53. Key Industry Trends of Canine Vaccine
Table 54. Canine Vaccine Raw Material
Table 55. Key Suppliers of Raw Materials
Table 56. Canine Vaccine Distributors List
Table 57. Canine Vaccine Customer List
Table 58. Global Canine Vaccine Sales Forecast by Region (2027-2032) & (K Units)
Table 59. Global Canine Vaccine Revenue Forecast by Region (2027-2032) & ($ millions)
Table 60. Americas Canine Vaccine Sales Forecast by Country (2027-2032) & (K Units)
Table 61. Americas Canine Vaccine Annual Revenue Forecast by Country (2027-2032) & ($ millions)
Table 62. APAC Canine Vaccine Sales Forecast by Region (2027-2032) & (K Units)
Table 63. APAC Canine Vaccine Annual Revenue Forecast by Region (2027-2032) & ($ millions)
Table 64. Europe Canine Vaccine Sales Forecast by Country (2027-2032) & (K Units)
Table 65. Europe Canine Vaccine Revenue Forecast by Country (2027-2032) & ($ millions)
Table 66. Middle East & Africa Canine Vaccine Sales Forecast by Country (2027-2032) & (K Units)
Table 67. Middle East & Africa Canine Vaccine Revenue Forecast by Country (2027-2032) & ($ millions)
Table 68. Global Canine Vaccine Sales Forecast by Type (2027-2032) & (K Units)
Table 69. Global Canine Vaccine Revenue Forecast by Type (2027-2032) & ($ millions)
Table 70. Global Canine Vaccine Sales Forecast by Application (2027-2032) & (K Units)
Table 71. Global Canine Vaccine Revenue Forecast by Application (2027-2032) & ($ millions)
Table 72. Zoetis Basic Information, Canine Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 73. Zoetis Canine Vaccine Product Portfolios and Specifications
Table 74. Zoetis Canine Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 75. Zoetis Main Business
Table 76. Zoetis Latest Developments
Table 77. Merck Animal Health Basic Information, Canine Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 78. Merck Animal Health Canine Vaccine Product Portfolios and Specifications
Table 79. Merck Animal Health Canine Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 80. Merck Animal Health Main Business
Table 81. Merck Animal Health Latest Developments
Table 82. Pfizer Basic Information, Canine Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 83. Pfizer Canine Vaccine Product Portfolios and Specifications
Table 84. Pfizer Canine Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 85. Pfizer Main Business
Table 86. Pfizer Latest Developments
Table 87. Boehringer Ingelheim Basic Information, Canine Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 88. Boehringer Ingelheim Canine Vaccine Product Portfolios and Specifications
Table 89. Boehringer Ingelheim Canine Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 90. Boehringer Ingelheim Main Business
Table 91. Boehringer Ingelheim Latest Developments
Table 92. Virbac Basic Information, Canine Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 93. Virbac Canine Vaccine Product Portfolios and Specifications
Table 94. Virbac Canine Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 95. Virbac Main Business
Table 96. Virbac Latest Developments
Table 97. Durvet Basic Information, Canine Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 98. Durvet Canine Vaccine Product Portfolios and Specifications
Table 99. Durvet Canine Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 100. Durvet Main Business
Table 101. Durvet Latest Developments
Table 102. Elanco Basic Information, Canine Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 103. Elanco Canine Vaccine Product Portfolios and Specifications
Table 104. Elanco Canine Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 105. Elanco Main Business
Table 106. Elanco Latest Developments
Table 107. RuiPu Bio-Technology Basic Information, Canine Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 108. RuiPu Bio-Technology Canine Vaccine Product Portfolios and Specifications
Table 109. RuiPu Bio-Technology Canine Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 110. RuiPu Bio-Technology Main Business
Table 111. RuiPu Bio-Technology Latest Developments
Table 112. CAHIC Basic Information, Canine Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 113. CAHIC Canine Vaccine Product Portfolios and Specifications
Table 114. CAHIC Canine Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 115. CAHIC Main Business
Table 116. CAHIC Latest Developments
Table 117. Wuhan Keqian Biology Basic Information, Canine Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 118. Wuhan Keqian Biology Canine Vaccine Product Portfolios and Specifications
Table 119. Wuhan Keqian Biology Canine Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 120. Wuhan Keqian Biology Main Business
Table 121. Wuhan Keqian Biology Latest Developments
Table 122. Jilin Five-Star Animal Health Basic Information, Canine Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 123. Jilin Five-Star Animal Health Canine Vaccine Product Portfolios and Specifications
Table 124. Jilin Five-Star Animal Health Canine Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 125. Jilin Five-Star Animal Health Main Business
Table 126. Jilin Five-Star Animal Health Latest Developments
Table 127. NeoTech Basic Information, Canine Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 128. NeoTech Canine Vaccine Product Portfolios and Specifications
Table 129. NeoTech Canine Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 130. NeoTech Main Business
Table 131. NeoTech Latest Developments
Table 132. JINHE Basic Information, Canine Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 133. JINHE Canine Vaccine Product Portfolios and Specifications
Table 134. JINHE Canine Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 135. JINHE Main Business
Table 136. JINHE Latest Developments
Table 137. SINOVAC Basic Information, Canine Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 138. SINOVAC Canine Vaccine Product Portfolios and Specifications
Table 139. SINOVAC Canine Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 140. SINOVAC Main Business
Table 141. SINOVAC Latest Developments
Table 142. Biogenesis Bago Basic Information, Canine Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 143. Biogenesis Bago Canine Vaccine Product Portfolios and Specifications
Table 144. Biogenesis Bago Canine Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 145. Biogenesis Bago Main Business
Table 146. Biogenesis Bago Latest Developments
LIST OF FIGURES
Figure 1. Picture of Canine Vaccine
Figure 2. Canine Vaccine Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Canine Vaccine Sales Growth Rate 2021-2032 (K Units)
Figure 7. Global Canine Vaccine Revenue Growth Rate 2021-2032 ($ millions)
Figure 8. Canine Vaccine Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 9. Canine Vaccine Sales Market Share by Country/Region (2025)
Figure 10. Canine Vaccine Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 11. Product Picture of Core Vaccines
Figure 12. Product Picture of Non-Core Vaccines
Figure 13. Global Canine Vaccine Sales Market Share by Type in 2026
Figure 14. Global Canine Vaccine Revenue Market Share by Type (2021-2026)
Figure 15. Canine Vaccine Consumed in Puppies
Figure 16. Global Canine Vaccine Market: Puppies (2021-2026) & (K Units)
Figure 17. Canine Vaccine Consumed in Adult Dogs
Figure 18. Global Canine Vaccine Market: Adult Dogs (2021-2026) & (K Units)
Figure 19. Global Canine Vaccine Sale Market Share by Application (2025)
Figure 20. Global Canine Vaccine Revenue Market Share by Application in 2026
Figure 21. Canine Vaccine Sales by Company in 2026 (K Units)
Figure 22. Global Canine Vaccine Sales Market Share by Company in 2026
Figure 23. Canine Vaccine Revenue by Company in 2026 ($ millions)
Figure 24. Global Canine Vaccine Revenue Market Share by Company in 2026
Figure 25. Global Canine Vaccine Sales Market Share by Geographic Region (2021-2026)
Figure 26. Global Canine Vaccine Revenue Market Share by Geographic Region in 2026
Figure 27. Americas Canine Vaccine Sales 2021-2026 (K Units)
Figure 28. Americas Canine Vaccine Revenue 2021-2026 ($ millions)
Figure 29. APAC Canine Vaccine Sales 2021-2026 (K Units)
Figure 30. APAC Canine Vaccine Revenue 2021-2026 ($ millions)
Figure 31. Europe Canine Vaccine Sales 2021-2026 (K Units)
Figure 32. Europe Canine Vaccine Revenue 2021-2026 ($ millions)
Figure 33. Middle East & Africa Canine Vaccine Sales 2021-2026 (K Units)
Figure 34. Middle East & Africa Canine Vaccine Revenue 2021-2026 ($ millions)
Figure 35. Americas Canine Vaccine Sales Market Share by Country in 2026
Figure 36. Americas Canine Vaccine Revenue Market Share by Country (2021-2026)
Figure 37. Americas Canine Vaccine Sales Market Share by Type (2021-2026)
Figure 38. Americas Canine Vaccine Sales Market Share by Application (2021-2026)
Figure 39. United States Canine Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 40. Canada Canine Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 41. Mexico Canine Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 42. Brazil Canine Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 43. APAC Canine Vaccine Sales Market Share by Region in 2026
Figure 44. APAC Canine Vaccine Revenue Market Share by Region (2021-2026)
Figure 45. APAC Canine Vaccine Sales Market Share by Type (2021-2026)
Figure 46. APAC Canine Vaccine Sales Market Share by Application (2021-2026)
Figure 47. China Canine Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 48. Japan Canine Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 49. South Korea Canine Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 50. Southeast Asia Canine Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 51. India Canine Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 52. Australia Canine Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 53. China Taiwan Canine Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 54. Europe Canine Vaccine Sales Market Share by Country in 2026
Figure 55. Europe Canine Vaccine Revenue Market Share by Country (2021-2026)
Figure 56. Europe Canine Vaccine Sales Market Share by Type (2021-2026)
Figure 57. Europe Canine Vaccine Sales Market Share by Application (2021-2026)
Figure 58. Germany Canine Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 59. France Canine Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 60. UK Canine Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 61. Italy Canine Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 62. Russia Canine Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 63. Middle East & Africa Canine Vaccine Sales Market Share by Country (2021-2026)
Figure 64. Middle East & Africa Canine Vaccine Sales Market Share by Type (2021-2026)
Figure 65. Middle East & Africa Canine Vaccine Sales Market Share by Application (2021-2026)
Figure 66. Egypt Canine Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 67. South Africa Canine Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 68. Israel Canine Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 69. Turkey Canine Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 70. GCC Countries Canine Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 71. Manufacturing Cost Structure Analysis of Canine Vaccine in 2026
Figure 72. Manufacturing Process Analysis of Canine Vaccine
Figure 73. Industry Chain Structure of Canine Vaccine
Figure 74. Channels of Distribution
Figure 75. Global Canine Vaccine Sales Market Forecast by Region (2027-2032)
Figure 76. Global Canine Vaccine Revenue Market Share Forecast by Region (2027-2032)
Figure 77. Global Canine Vaccine Sales Market Share Forecast by Type (2027-2032)
Figure 78. Global Canine Vaccine Revenue Market Share Forecast by Type (2027-2032)
Figure 79. Global Canine Vaccine Sales Market Share Forecast by Application (2027-2032)
Figure 80. Global Canine Vaccine Revenue Market Share Forecast by Application (2027-2032)
Figure 1. Picture of Canine Vaccine
Figure 2. Canine Vaccine Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Canine Vaccine Sales Growth Rate 2021-2032 (K Units)
Figure 7. Global Canine Vaccine Revenue Growth Rate 2021-2032 ($ millions)
Figure 8. Canine Vaccine Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 9. Canine Vaccine Sales Market Share by Country/Region (2025)
Figure 10. Canine Vaccine Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 11. Product Picture of Core Vaccines
Figure 12. Product Picture of Non-Core Vaccines
Figure 13. Global Canine Vaccine Sales Market Share by Type in 2026
Figure 14. Global Canine Vaccine Revenue Market Share by Type (2021-2026)
Figure 15. Canine Vaccine Consumed in Puppies
Figure 16. Global Canine Vaccine Market: Puppies (2021-2026) & (K Units)
Figure 17. Canine Vaccine Consumed in Adult Dogs
Figure 18. Global Canine Vaccine Market: Adult Dogs (2021-2026) & (K Units)
Figure 19. Global Canine Vaccine Sale Market Share by Application (2025)
Figure 20. Global Canine Vaccine Revenue Market Share by Application in 2026
Figure 21. Canine Vaccine Sales by Company in 2026 (K Units)
Figure 22. Global Canine Vaccine Sales Market Share by Company in 2026
Figure 23. Canine Vaccine Revenue by Company in 2026 ($ millions)
Figure 24. Global Canine Vaccine Revenue Market Share by Company in 2026
Figure 25. Global Canine Vaccine Sales Market Share by Geographic Region (2021-2026)
Figure 26. Global Canine Vaccine Revenue Market Share by Geographic Region in 2026
Figure 27. Americas Canine Vaccine Sales 2021-2026 (K Units)
Figure 28. Americas Canine Vaccine Revenue 2021-2026 ($ millions)
Figure 29. APAC Canine Vaccine Sales 2021-2026 (K Units)
Figure 30. APAC Canine Vaccine Revenue 2021-2026 ($ millions)
Figure 31. Europe Canine Vaccine Sales 2021-2026 (K Units)
Figure 32. Europe Canine Vaccine Revenue 2021-2026 ($ millions)
Figure 33. Middle East & Africa Canine Vaccine Sales 2021-2026 (K Units)
Figure 34. Middle East & Africa Canine Vaccine Revenue 2021-2026 ($ millions)
Figure 35. Americas Canine Vaccine Sales Market Share by Country in 2026
Figure 36. Americas Canine Vaccine Revenue Market Share by Country (2021-2026)
Figure 37. Americas Canine Vaccine Sales Market Share by Type (2021-2026)
Figure 38. Americas Canine Vaccine Sales Market Share by Application (2021-2026)
Figure 39. United States Canine Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 40. Canada Canine Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 41. Mexico Canine Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 42. Brazil Canine Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 43. APAC Canine Vaccine Sales Market Share by Region in 2026
Figure 44. APAC Canine Vaccine Revenue Market Share by Region (2021-2026)
Figure 45. APAC Canine Vaccine Sales Market Share by Type (2021-2026)
Figure 46. APAC Canine Vaccine Sales Market Share by Application (2021-2026)
Figure 47. China Canine Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 48. Japan Canine Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 49. South Korea Canine Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 50. Southeast Asia Canine Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 51. India Canine Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 52. Australia Canine Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 53. China Taiwan Canine Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 54. Europe Canine Vaccine Sales Market Share by Country in 2026
Figure 55. Europe Canine Vaccine Revenue Market Share by Country (2021-2026)
Figure 56. Europe Canine Vaccine Sales Market Share by Type (2021-2026)
Figure 57. Europe Canine Vaccine Sales Market Share by Application (2021-2026)
Figure 58. Germany Canine Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 59. France Canine Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 60. UK Canine Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 61. Italy Canine Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 62. Russia Canine Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 63. Middle East & Africa Canine Vaccine Sales Market Share by Country (2021-2026)
Figure 64. Middle East & Africa Canine Vaccine Sales Market Share by Type (2021-2026)
Figure 65. Middle East & Africa Canine Vaccine Sales Market Share by Application (2021-2026)
Figure 66. Egypt Canine Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 67. South Africa Canine Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 68. Israel Canine Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 69. Turkey Canine Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 70. GCC Countries Canine Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 71. Manufacturing Cost Structure Analysis of Canine Vaccine in 2026
Figure 72. Manufacturing Process Analysis of Canine Vaccine
Figure 73. Industry Chain Structure of Canine Vaccine
Figure 74. Channels of Distribution
Figure 75. Global Canine Vaccine Sales Market Forecast by Region (2027-2032)
Figure 76. Global Canine Vaccine Revenue Market Share Forecast by Region (2027-2032)
Figure 77. Global Canine Vaccine Sales Market Share Forecast by Type (2027-2032)
Figure 78. Global Canine Vaccine Revenue Market Share Forecast by Type (2027-2032)
Figure 79. Global Canine Vaccine Sales Market Share Forecast by Application (2027-2032)
Figure 80. Global Canine Vaccine Revenue Market Share Forecast by Application (2027-2032)
